Sun et al. found that NLRP3 activation promotes phenotypic transformation and proliferation of hypertensive VSMCs, and subsequent studies confirmed its role in hypertension through pharmacological inhibition of NLRP3 (40, 41). The gene discussed is NLRP3; the disease is hypertensive disorder.